Melanie Senior

Writer & Analyst at Nature, Evaluate, IN VIVO

Speaker

I write about biopharmaceutical science, strategy, investment and market access for Nature Biotechnology, Evaluate Pharma and IN VIVO. I also support companies and associations with white papers, market analyses and in formulating their mission and market positioning.

After beginning my career at the London Financial Times, I became Bureau Chief, Europe, for Elsevier Business Intelligence. I worked as a reimbursement and pricing analyst for Real Endpoints in the US and was part of EY Life Sciences’ thought leadership team between 2014-2017.

I have a First Class degree in Natural Sciences (biochemistry) from Cambridge University and post-graduate qualifications in Sports Physiology & Nutrition (St Mary’s University) and in International Health Technology Assessment (University of Sheffield). I’m based in London, UK.